1st Oct 2013 11:05
LONDON (Alliance News) - Shares in Physiomics PLC jumped up 78% after it said Tuesday that it had signed a contract with a pharma customer to supply cardiac toxicity risk modelling services. The initial contract is for 12 months, although the company gave no financial details of the contract or the name of the customer.
The biotechnology company were trading up 78% at 0.200 pence Tuesday afternoon.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Physiomics